Furthermore, in the present study, placental sclerostin and LRP5 expression in women with GDM was significantly greater than in pregnant women without GDM, whereas placental sclerostin expression correlated positively with second-trimester maternal fasting glucose concentrations. This evidence concerns the gene LRP5 and gestational diabetes.